Bear of the Day: Winnebago (WGO) - Bear of the Day
Todd Bunton - ZACKS - Thu Dec 25, 12:00AM CST
Bear of the Day: Winnebago (WGO) - Bear of the Day
WGO: 22.64 (+0.25), THOR: 32.81 (+0.74)
Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)
Insider Trading Alert - THOR, NXTM And AAON Traded By Insiders
at The Street - Tue Dec 09, 10:37AM CST
Stocks with insider trader activity include THOR, NXTM and AAON
NXTM: 18.39 (+0.33), AAON: 22.41 (+0.24), THOR: 32.81 (+0.74)
Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:10PM CST
Thoratec Corp (THOR) recently completed enrolment of 50 patients under the HeartMate III CE Mark trial at ten sites across Europe, Canada, and Australia.
FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), THOR: 32.81 (+0.74), ANGO: 19.19 (+0.33)
Thoratec Announces Completion Of Enrollment In The HeartMate III(TM) CE Mark Trial
PR Newswire - Mon Dec 01, 8:00AM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced completion of enrollment in the HeartMate III CE Mark trial. This trial enrolled a total of 50 patients at ten sites across Europe, Canada, and Australia.
THOR: 32.81 (+0.74)
Thoratec: At The Heart Of A Health-Related Investment Strategy
Robert Honeywill - at Seeking Alpha - Sun Nov 30, 3:48AM CST
About the headline It is my contention, for Western economies, we will enjoy far lower growth in the future than we have enjoyed over the last several decades. For investors, it is not an optimal strategy to adopt a "rising tide lifts all boats"...
SSH: 4.04 (+0.19), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02)
Thoratec Announces Presentations At Investor Conferences For December 2014
PR Newswire - Wed Nov 26, 8:00AM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
THOR: 32.81 (+0.74)
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Thoratec Is Up 14.3% (THOR)
Comtex SmarTrend(R) - Mon Nov 24, 9:28AM CST
Two weeks ago on November 5th, 2014 Thoratec (NASDAQ:THOR) reported earnings and analysts, on average, expected earnings of $0.20 on sales of $105.2 million. Thoratec actually reported earnings of $0.18 per share on sales of $105.8 million, missing EPS estimates by $0.02 and beating revenue estimates by $0.6 million. Since the company's report, shares of Thoratec have risen from $27.04 to $30.90, representing a gain of 14.3% in the past 19 days.
THOR: 32.81 (+0.74)
Upgrade Alert for Thoratec (THOR)
Comtex SmarTrend(R) - Tue Nov 18, 7:02AM CST
Thoratec (NASDAQ:THOR) was upgraded from Neutral to Outperform at Credit Suisse today. The stock closed yesterday at $29.20 on volume of 1.9 million shares, above average daily volume of 836,000. In the past 52 weeks, shares of Thoratec have traded between a low of $22.50 and a high of $43.50 and closed yesterday at $29.20, which is 30% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 0.9%.
THOR: 32.81 (+0.74)
Thoratec Earnings In Retrospect: Up 10.2% in the Last 12 Days (THOR)
Comtex SmarTrend(R) - Mon Nov 17, 3:29PM CST
When Thoratec (NASDAQ:THOR) reported earnings 12 days ago on November 5th, 2014, analysts, on average, expected the company to report earnings of $0.20 on sales of $105.2 million. The company actually reported EPS of $0.18 on sales of $105.8 million, missing EPS estimates by $0.02 and beating revenue estimates by $0.6 million. Since the company's report, shares of Thoratec have risen from $27.04 to $29.80, representing a gain of 10.2% in the past 12 days.
THOR: 32.81 (+0.74)
Update: Thoratec Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sat Nov 15, 7:28AM CST
THOR: 32.81 (+0.74)
Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 38.46 (+0.13), EW: 130.75 (+1.17), THOR: 32.81 (+0.74), ANGO: 19.19 (+0.33)
Downtrend Call Working As Thoratec Stock Falls 16.3% (THOR)
Comtex SmarTrend(R) - Wed Nov 12, 10:02AM CST
SmarTrend identified a Downtrend for Thoratec (NASDAQ:THOR) on July 16th, 2014 at $33.13. In approximately 4 months, Thoratec has returned 16.33% as of today's recent price of $27.72.
THOR: 32.81 (+0.74)
Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 38.46 (+0.13), CYNO: 28.00 (-0.04), THOR: 32.81 (+0.74), ANGO: 19.19 (+0.33)
Thoratec Announces Presentations At Investor Conferences For November 2014
PR Newswire - Thu Nov 06, 8:15AM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
THOR: 32.81 (+0.74)
Thoratec's (THOR) CEO Keith Grossman on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 10:32PM CST
THOR: 32.81 (+0.74)
Thoratec misses 3Q profit forecasts
Automated Insights - Wed Nov 05, 5:21PM CST
PLEASANTON, Calif. (AP) _ Thoratec Corp. (THOR) on Wednesday reported net income of $2.9 million in its third quarter.
THOR: 32.81 (+0.74)
Thoratec misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:52PM CST
THOR: 32.81 (+0.74)